Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy

A number of plasma lipid parameters have been used to estimate cardiovascular risk and to be targets for treatment to reduce risk. Most risk algorithms are based on total cholesterol (T-C) or low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), and most inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiklund, Olov, Pirazzi, Carlo, Romeo, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751280/
https://www.ncbi.nlm.nih.gov/pubmed/23888382
http://dx.doi.org/10.1007/s11886-013-0397-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751280/
https://www.ncbi.nlm.nih.gov/pubmed/23888382
http://dx.doi.org/10.1007/s11886-013-0397-8

Ejemplares similares